MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..19 of 19 - per page Previous page
Order by
New pharmaceutical compositions for oral use containing diclofenac together with alkali metal carbonates and bicarbonates and particular flavouring substances. More
For oral formulations; particles are coated More
For rapid dispersion in mouth or glass of water. More
Multilayered controlled release oral solid pharmaceutical composition in tablet form suitable for oral administration comprising at least two layers containing active material in association with excipients and additives. More
Patented technology regarding a superior adjuvant with the active substance polysaccharide for oral/nasal vaccines against influenza and bird influenza, targeted to the aging population. More
Rubicon has developed a pleasant tasting, robust, orodispersible tablet which can be packed in unit dose blister packs. This provides an excellent opportunity for product differentiation due to improved patient convenience. More
It is patented combination of standardized extracts and is clinically proven (n= 77) to reduce Calculi surface area, pain and to maintain Complete Kidney Health by preventing reoccurrence of stones.. More
Rubicon has developed a Controlled Release Tablet of Vitamin C using its patented technology that ensures steady release of Vitamin C over 12 hours. The flavored coating provides a pleasant swallowing experience. More
A therapeutically active polypeptide is covalently attached directly to vitamin B12 or via a spacer. The pharmaceutical composition can be in the form of a capsule, tablet, emulsion, colloidal dispersion, elixir, gel, gum, or paste. More
Displaying 11..19 of 19 - per page Previous page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us